Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine TAP block with versus without adrenaline
ACTRN12612000842864Phase 4Completed
- Sponsor
- A/Prof John Loadsman
- Start
- Sep 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine and epinephrine in postoperative pain (2 arms), sponsored by A/Prof John Loadsman. Primary endpoint: Plasma ropivacaine concentration at 180 minutes. Started Sep 2012; status: completed.
02
Drugs
ropivacaineepinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12612000842864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000842864.